Precision pathways: Insights & strategies to navigate regulatory requirements for oncology diagnostics

Watch as we explore the evolving regulatory landscape of diagnostics in oncology. Gain insights into new regulatory requirements, submission pathways, and emerging trends. Learn from industry experts about strategic approaches to FDA requirements to help inform your diagnostic development and precision medicine pipelines.

Watch replay

Revolutionizing drug screening with Tempus AI’s advanced imaging capabilities

Learn how Tempus AI's noninvasive imaging techniques allow for the continuous study of the same organoids across various assays, preserving their viability for longitudinal analysis and multiplexed testing.

Read more

Shaping drug development with tumor organoids and RWD

Explore how Tempus addresses drug development challenges through its extensive 3D patient-derived organoid (PDO) biorepository and real-world data (RWD) platform.

Watch replay